Danaher Corporation (DHR)

Currency in USD
250.50
0.00(0.00%)
Closed·
Trading near 52-week High
Fair Value
Day's Range
250.50250.50
52 wk Range
250.50250.50
Key Statistics
Prev. Close
250.5
Open
250.5
Day's Range
250.5-250.5
52 wk Range
250.5-250.5
Volume
-
Average Volume (3m)
411
1-Year Change
0%
Book Value / Share
68.59
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DHR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Danaher Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Danaher Corporation Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The company has a partnership with AstraZeneca PLC to develop and commercialize diagnostic tools and tests. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.

Employees
62000
Market
Peru

Compare DHR to Peers and Sector

Metrics to compare
DHR
Peers
Sector
Relationship
P/E Ratio
36.4x5.6x−0.5x
PEG Ratio
−2.060.090.00
Price/Book
2.9x1.5x2.6x
Price / LTM Sales
5.9x4.5x3.2x
Upside (Analyst Target)
-30.3%43.8%
Fair Value Upside
Unlock15.5%5.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.19%
Dividend Yield
0.51%
Annualized payout
1.28
Paid quarterly
5-Years Growth
+10.37%
Growth Streak

Earnings

Latest Release
Apr 22, 2025
EPS / Forecast
1.88 / 1.62
Revenue / Forecast
5.74B / 5.56B
EPS Revisions
Last 90 days

DHR Income Statement

People Also Watch

340.07
SHW
+0.05%
13.290
ACHR
-0.82%
268.75
ECL
-0.10%
274.17
CB
-0.47%

FAQ

What Is the Danaher Corporation (DHR) Stock Price Today?

The Danaher Corporation stock price today is 250.50

What Stock Exchange Does Danaher Corporation Trade On?

Danaher Corporation is listed and trades on the Lima Stock Exchange stock exchange.

What Is the Stock Symbol for Danaher Corporation?

The stock symbol for Danaher Corporation is "DHR."

Does Danaher Corporation Pay Dividends? What’s The Current Dividend Yield?

The Danaher Corporation dividend yield is 0.51%.

What Is the Danaher Corporation Market Cap?

As of today, Danaher Corporation market cap is 135.68B.

What Is Danaher Corporation's Earnings Per Share (TTM)?

The Danaher Corporation EPS (TTM) is 5.19.

When Is the Next Danaher Corporation Earnings Date?

Danaher Corporation will release its next earnings report on Jul 22, 2025.

From a Technical Analysis Perspective, Is DHR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Danaher Corporation Stock Split?

Danaher Corporation has split 0 times.

How Many Employees Does Danaher Corporation Have?

Danaher Corporation has 62000 employees.

What is the current trading status of Danaher Corporation (DHR)?

As of Jul 19, 2025, Danaher Corporation (DHR) is trading at a price of 250.50, with a previous close of 250.50. The stock has fluctuated within a day range of 250.50 to 250.50, while its 52-week range spans from 250.50 to 250.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.